| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |